Vaxart director Bono receives stock and option awards
Both awards vest over the first three grant-date anniversaries, subject to Raquel C. Bono's continued service on Vaxart's Board.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Vaxart, Inc. director Raquel C. Bono reported a restricted-stock-unit award covering 78,800 common shares and a stock-option award for 157,400 common shares on October 16, 2026. Both awards vest in equal installments on each of the first three anniversaries of the grant date, subject to her continuing service on the Board. The options have a $0.4527 exercise price and expire October 16, 2036.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) F2 | 157,400 | $0.00 | $0.00 |
| Grant/Award | Common Stock F1 | 78,800 | $0.00 | $0.00 |
Footnotes (2)
- F1. Grant of shares upon vesting of restricted stock units. The shares underlying the award shall vest in equal installments on each of the first three anniversaries of the grant date, subject to the reporting person's continuing service on the Board of Directors (the "Board").
- F2. The shares subject to this option shall vest in equal installments on each of the first three anniversaries of the grant date, subject to the reporting person's continuing service on the Board.
Key Figures
Key Terms
restricted stock units financial
vest financial
exercise price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What is the exercise price and expiration date for Raquel C. Bono's VXRT options?
AI-generated analysis. How Rhea-AI works. Not financial advice.